Ethics
All participants signed the written informed consent before initiating
the study. The study was approved by the Ethics Committee of Shiraz
University of Medical Sciences, Shiraz, Iran (registration no.
IR.SUMS.REC.1395.22) and was registered at Iranian Registry of Clinical
Trials website (IRCT2016050327733N1).
REFRENCES:
1. Woo JG, Guerrero ML, Ruiz-Palacios
GM, Peng Y-m, Herbers PM, Yao W, et al. Specific infant feeding
practices do not consistently explain variation in anthropometry at age
1 year in urban United States, Mexico, and China cohorts. The Journal of
nutrition. 2013;143(2):166-74.
2. Vriz O, Lu H, Visentin P, Nicolosi
L, Mos L, Palatini P. Gender differences in the relationship between
left ventricular size and ambulatory blood pressure in borderline
hypertension. The HARVEST Study. European heart journal.
1997;18(4):664-70.
3. Fukumitsu S, Aida K, Ueno N, Ozawa
S, Takahashi Y, Kobori M. Flaxseed lignan attenuates high-fat
diet-induced fat accumulation and induces adiponectin expression in
mice. British journal of nutrition. 2008;100(03):669-76.
4. Matsuzawa Y, Funahashi T, Nakamura
T. Molecular Mechanism of Metabolic Syndrome X: Contribution of
Adipocytokines· Adipocyte‐derived Bioactive Substances. Annals of the
New York Academy of Sciences. 1999;892(1):146-54.
5. Haluzik M, Parizkova J, Haluzik M.
Adiponectin and its role in the obesity-induced insulin resistance and
related complications. Physiological Research. 2004;53(2):123-30.
6. Iacobellis G, Pistilli D, Gucciardo
M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in
human epicardial adipose tissue in vivo is lower in patients with
coronary artery disease. Cytokine. 2005;29(6):251-5.
7. McCullough RS, Edel AL, Bassett CM,
LaVallée RK, Dibrov E, Blackwood DP, et al. The alpha linolenic acid
content of flaxseed is associated with an induction of adipose leptin
expression. Lipids. 2011;46(11):1043-52.
8. Zhou Y, Rui L. Leptin signaling and
leptin resistance. Frontiers of medicine. 2013;7(2):207-22.
9. Beaulieu A, Poncin G,
Belaid-Choucair Z, Humblet C, Bogdanovic G, Lognay G, et al. Leptin
reverts pro-apoptotic and antiproliferative effects of α-linolenic acids
in BCR-ABL positive leukemic cells: involvement of PI3K pathway. PloS
one. 2011;6(10):e25651.
10. Considine RV, Sinha MK, Heiman
ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum
immunoreactive-leptin concentrations in normal-weight and obese humans.
New England Journal of Medicine. 1996;334(5):292-5.
11. Park JB, Velasquez MT. Potential
effects of lignan-enriched flaxseed powder on bodyweight, visceral fat,
lipid profile, and blood pressure in rats. Fitoterapia.
2012;83(5):941-6.
12. Goyal A, Sharma V, Upadhyay N,
Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern
functional food. Journal of food science and technology.
2014;51(9):1633-53.
13. Yari Z, Rahimlou M, Poustchi H,
Hekmatdoost A. Flaxseed Supplementation in Metabolic Syndrome
Management: A Pilot Randomized, Open‐labeled, Controlled Study.
Phytotherapy Research. 2016;30(8):1339-44.
14. Daleprane JB, Batista A, Pacheco
JT, Da Silva AF, Costa CA, de Castro Resende Â, et al. Dietary flaxseed
supplementation improves endothelial function in the mesenteric arterial
bed. Food research international. 2010;43(8):2052-6.
15. Yang WS, Lee WJ, Funahashi T,
Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight
reduction increases plasma levels of an adipose-derived
anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001
Aug;86(8):3815-9.
16. Barre D, Mizier-Barre K, Stelmach
E, Hobson J, Griscti O, Rudiuk A, et al. Flaxseed lignan complex
administration in older human Type 2 diabetics manages central obesity
and prothrombosis—an invitation to further investigation into
polypharmacy reduction. Journal of nutrition and metabolism. 2012;2012.
17. Blüher S, Mantzoros CS. Leptin in
humans: lessons from translational research. The American journal of
clinical nutrition. 2009;89(3):991S-7S.
18. Machado AM, de Paula H, Cardoso
LD, Costa NM. Effects of brown and golden flaxseed on the lipid profile,
glycemia, inflammatory biomarkers, blood pressure and body composition
in overweight adolescents. Nutrition. 2015;31(1):90-6.
19. Khalatbari Soltani S, Jamaluddin
R, Tabibi H, Yusof M, Nisak B, Atabak S, et al. Effects of flaxseed
consumption on systemic inflammation and serum lipid profile in
hemodialysis patients with lipid abnormalities. Hemodialysis
International. 2013;17(2):275-81.
20. Bloedon LT, Szapary PO. Flaxseed
and cardiovascular risk. Nutrition reviews. 2004;62(1):18-27.
21. Pan A, Yu D, Demark-Wahnefried W,
Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions
on blood lipids. The American journal of clinical nutrition.
2009;90(2):288-97.
22. Fukumitsu S, Aida K, Shimizu H,
Toyoda K. Flaxseed lignan lowers blood cholesterol and decreases liver
disease risk factors in moderately hypercholesterolemic men. Nutrition
research (New York, NY). 2010;30(7):441-6.
23. Wang, M., Zhang, XJ., Feng,
K. et al. Dietary α-linolenic acid-rich flaxseed oil prevents
against alcoholic hepatic steatosis via ameliorating lipid
homeostasis at adipose tissue-liver axis in mice. Sci
Rep 6, 26826 (2016).
24. Jump DB, Botolin D, Wang Y, Xu J,
Christian B, Demeure O. Fatty acid regulation of hepatic gene
transcription. The Journal of nutrition. 2005;135(11):2503-6.
25. Felmlee MA, Woo G, Simko E, Krol
ES, Muir AD, Alcorn J. Effects of the flaxseed lignans
secoisolariciresinol diglucoside and its aglycone on serum and hepatic
lipids in hyperlipidaemic rats. The British journal of nutrition.
2009;102(3):361-9.
26. Park JB, Velasquez MT. Potential
effects of lignan-enriched flaxseed powder on bodyweight, visceral fat,
lipid profile, and blood pressure in rats. Fitoterapia.
2012;83(5):941-6.
27. Pellizzon MA, Billheimer JT,
Bloedon LT, Szapary PO, Rader DJ. Flaxseed reduces plasma cholesterol
levels in hypercholesterolemic mouse models. Journal of the American
College of Nutrition. 2007;26(1):66-75.
28. Prasad K, Mantha S, Muir A,
Westcott N. Reduction of hypercholesterolemic atherosclerosis by
CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis.
1998;136(2):367-75.
29. Cornish SM, Chilibeck PD,
Paus-Jennsen L, Biem HJ, Khozani T, Senanayake V, et al. A randomized
controlled trial of the effects of flaxseed lignan complex on metabolic
syndrome composite score and bone mineral in older adults. Applied
Physiology, Nutrition, and Metabolism. 2009;34(2):89-98.
30. Lemay A, Dodin S, Kadri N,
Jacques H, Forest J-C. Flaxseed dietary supplement versus hormone
replacement therapy in hypercholesterolemic menopausal women. Obstetrics
& Gynecology. 2002;100(3):495-504.
31. Nelson TL, Stevens JR, Hickey MS.
Adiponectin levels are reduced, independent of polymorphisms in the
adiponectin gene, after supplementation with α-linolenic acid among
healthy adults. Metabolism. 2007;56(9):1209-15.
32. Dent E, Kowal P, Hoogendijk EO.
Frailty measurement in research and clinical practice: A review.
European journal of internal medicine. 2016;31:3-10.
33. Mahan LK, Raymond JL. Krause’s
Food & the Nutrition Care Process-E-Book: Elsevier Health Sciences;
2016.
34. Park JB, Velasquez MT. Potential
effects of lignan-enriched flax seed powder on blood pressure, fat
accumulation, and lipid profile in rats. The FASEB Journal.
2011;25(1_MeetingAbstracts):339.6.
35. Wu H, Pan A, Yu Z, Qi Q, Lu L,
Zhang G, et al. Lifestyle counseling and supplementation with flaxseed
or walnuts influence the management of metabolic syndrome. The Journal
of nutrition. 2010;140(11):1937-42.
36. Pineda AMR, Gómez BLG, Alzate
CMA, Castaño CFM, Marín BEL. Consumo de linaza molida para la reducción
de peso corporal en personas con exceso de peso. Perspectivas en
Nutrición Humana. 2011;13(1):56.
37. Taylor CG, Noto AD, Stringer DM,
Froese S, Malcolmson L. Dietary milled flaxseed and flaxseed oil improve
N-3 fatty acid status and do not affect glycemic control in individuals
with well-controlled type 2 diabetes. J Am Coll Nutr. 2010
Feb;29(1):72-80.
38. Prasad K. Reduction of serum
cholesterol and hypercholesterolemic atherosclerosis in rabbits by
secoisolariciresinol diglucoside isolated from flaxseed. Circulation.
1999;99(10):1355-62.
39. Kratz M, Swarbrick MM, Callahan
HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n–3
polyunsaturated fatty acids on plasma total and high-molecular-weight
adiponectin concentrations in overweight to moderately obese men and
women. The American journal of clinical nutrition. 2008;87(2):347-53.
40. Hallund J, Ravn-Haren G, Bügel S,
Tholstrup T, Tetens I. A lignan complex isolated from flaxseed does not
affect plasma lipid concentrations or antioxidant capacity in healthy
postmenopausal women. The Journal of nutrition. 2006;136(1):112-6.
41. Cassani RSL, Fassini PG, Silvah
JH, Lima CMM, Marchini JS. Impact of weight loss diet associated with
flaxseed on inflammatory markers in men with cardiovascular risk
factors: a clinical study. Nutrition journal. 2015;14(1):5.
42. Hutchins AM, Brown BD, Cunnane
SC, Domitrovich SG, Adams ER, Bobowiec CE. Daily flaxseed consumption
improves glycemic control in obese men and women with pre-diabetes: a
randomized study. Nutrition Research. 2013;33(5):367-75.
43. Patel JV, Lee KW, Tomson J, Dubb
K, Hughes EA, Lip GY. Effects of omega-3 polyunsaturated fatty acids on
metabolically active hormones in patients post-myocardial infarction.
International journal of cardiology. 2007;115(1):42-5.
44. Weyer C, Funahashi T, Tanaka S,
Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity
and type 2 diabetes: close association with insulin resistance and
hyperinsulinemia. The Journal of Clinical Endocrinology & Metabolism.
2001;86(5):1930-5.
45. Flachs P, Mohamed-Ali V, Horakova
O, Rossmeisl M, Hosseinzadeh-Attar M, Hensler M, et al. Polyunsaturated
fatty acids of marine origin induce adiponectin in mice fed a high-fat
diet. Diabetologia. 2006;49(2):394-7.
46. Babcock TA, Novak T, Ong E, Jho
DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated
macrophage tumor necrosis factor-α production by ω-3 fatty acid is
associated with differential cyclooxygenase-2 protein expression and is
independent of interleukin-10. Journal of Surgical Research.
2002;107(1):135-9.
47. José-Manuel Fernández-Real, Joan Vendrell, Wifredo Ricart,
Circulating Adiponectin and Plasma Fatty Acid Profile, Clinical
Chemistry , Volume 51, Issue 3, 1 March 2005, Pages
603–609.
48. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional
regulation of adipogenesis. Genes & development. 2000;14(11):1293-307.
49. Hariri M, Ghiasvand R, Shiranian
A, Askari G, Iraj B, Salehi‐Abargouei A. Does omega‐3 fatty acids
supplementation affect circulating leptin levels? A systematic review
and meta‐analysis on randomized controlled clinical trials. Clinical
endocrinology. 2015;82(2):221-8.
50. Zhou YE, Kubow S, Dewailly E,
Julien P, Egeland GM. Decreased activity of desaturase 5 in association
with obesity and insulin resistance aggravates declining long-chain n-3
fatty acid status in Cree undergoing dietary transition. British journal
of nutrition. 2009;102(6):888-94.
51. Kaul N, Kreml R, Austria JA,
Richard MN, Edel AL, Dibrov E, et al. A comparison of fish oil, flaxseed
oil and hempseed oil supplementation on selected parameters of
cardiovascular health in healthy volunteers. J Am Coll Nutr.
2008;27(1):51-8.
52. Mandasescu S, Mocanu V, Dascalita
AM, Haliga R, Nestian I, Stitt PA, et al. Flaxseed supplementation in
hyperlipidemic patients. Revista medico-chirurgicala a Societatii de
Medici si Naturalisti din Iasi. 2005;109(3):502-6.
53. Patade A, Devareddy L, Lucas EA,
Korlagunta K, Daggy BP, Arjmandi BH. Flaxseed reduces total and LDL
cholesterol concentrations in Native American postmenopausal women.
Journal of women’s health (2002). 2008;17(3):355-66.
54. Torkan M, Hassan Entezari M,
Siavash M. Effect of flaxseed on blood lipid level in hyperlipidemic
patients. Reviews on recent clinical trials. 2015;10(1):61-7.
55. Zhang W, Wang X, Liu Y, Tian H,
Flickinger B, Empie MW, et al. Dietary flaxseed lignan extract lowers
plasma cholesterol and glucose concentrations in hypercholesterolaemic
subjects. British Journal of Nutrition. 2008;99(6):1301-9.
56. Paschos GK, Zampelas A,
Panagiotakos DB, Katsiougiannis S, Griffin BA, Votteas V, et al. Effects
of flaxseed oil supplementation on plasma adiponectin levels in
dyslipidemic men. European journal of nutrition. 2007;46(6):315-20.
57. Bloedon LT, Balikai S, Chittams
J, Cunnane SC, Berlin JA, Rader DJ, et al. Flaxseed and cardiovascular
risk factors: results from a double blind, randomized, controlled
clinical trial. J Am Coll Nutr. 2008;27(1):65-74.
58. Singh K, Mridula D, Rehal J,
Barnwal P. Flaxseed: a potential source of food, feed and fiber.
Critical reviews in food science and nutrition. 2011;51(3):210-22.
59.
Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, et al.
Sterol regulatory element-binding protein-1 as a key transcription
factor for nutritional induction of lipogenic enzyme genes. The Journal
of biological chemistry. 1999;274(50):35832-9.
60. Brown L, Rosner B, Willett WW,
Sacks FM. Cholesterol-lowering effects of dietary fiber: a
meta-analysis. Am J Clin Nutr. 1999;69(1):30-42.